Volume 129, Issue 3, 2022-3-1, Pages A3-e37 (March)

Articles in this issue:

1. Editorial Board 

2. Contents 

3. This Issue at a Glance 

4. A Simple Vista en Este Número 

5. 期刊一览 

6. Abstracts 

7. Abstracts 

8. Science Matters 

9. Endophthalmitis Rates among Medicare Beneficiaries Undergoing Cataract Surgery between 2011 and 2019 

10. The Impact of the Coronavirus Disease 2019 Pandemic on Adherence to Ocular Hypotensive Medication in Patients with Primary Open-Angle Glaucoma 

11. Ocular Biometric Risk Factors for Progression of Primary Angle Closure Disease 

12. Extraocular Extension of a Regressed Choroidal Melanoma after Vitrectomy and Scleral Buckle for Rhegmatogenous Retinal Detachment 

13. The Association among Blood Pressure, Blood Pressure Medications, and Glaucoma in a Nationwide Electronic Health Records Database 

14. High-Density Lipoprotein 3 Cholesterol and Primary Open-Angle Glaucoma 

15. Long-Term Follow-up of Epstein Viral Keratitis 

16. Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 

17. Residual Oil from Hydraulic Fluid Trauma Presenting as Discrete Periorbital Foreign Bodies 

18. Three-Year Clinical Trial of Low-Concentration Atropine for Myopia Progression (LAMP) Study: Continued Versus Washout 

19. Lipemia Retinalis in a Baby with Hyperlipoproteinemia 

20. Efficacy and Safety of 8 Atropine Concentrations for Myopia Control in Children 

21. Development of Glaucoma after Myopic Optic Disc Change in a Teenage Patient 

22. The Association between Noninfectious Uveitis and Coronavirus Disease 2019 Outcomes 

23. Incidence of Sympathetic Ophthalmia after Inciting Events 

24. Trends in Venture Capital Investments in Ophthalmology Companies (2011–2021) 

25. Trends in Remote Retinal Imaging Utilization and Payments in the United States 

26. Efficacy and Safety of Adalimumab and Infliximab for Noninfectious Uveitis 

27. Re: Chiang et al.: International Classification of Retinopathy of Prematurity, Third Edition ( Ophthalmology. 2021;128:e51–e68) 

28. Reply